alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<PAGE>


                                   EXHIBIT 4.6

                      SECOND AMENDMENT TO BROOKTROUT, INC.
                            1999 STOCK INCENTIVE PLAN

         This Second Amendment (the "Second Amendment") to the Brooktrout, Inc.
("Brooktrout" or the "Company") 1999 Stock Incentive Plan, dated December 8,
1999 (the "Plan"), was adopted by the Board of Directors (the "Board") of the
Company on October 9, 2001.

         WHEREAS, the Board believes that the availability of an adequate number
of shares of common stock, $.01 par value per share (the "Stock"), under the
Plan has been, and in the future will be, an important factor in attracting and
retaining the highest caliber employees of the Company;

         WHEREAS, the Board further believes that the number of shares of Stock,
available for issuance under the Plan is currently insufficient; and

         WHEREAS, the Board adopted an increase of four hundred thousand
(400,000) shares of Stock available for issuance under the Plan;

         NOW, THEREFORE, the Plan is hereby amended in the following manner: The
first sentence of Section 3 clause (a) is amended to increase the maximum number
of shares of Stock reserved and available for issuance under the Plan from nine
hundred thousand (900,000) to one million three hundred thousand (1,300,000).
Case 3:11-cv-00090-AET-LHG Document 1 Filed 01/06/11 Page 1 of 10 PageID: 1
Case 3:11-cv-00090-AET-LHG Document 1 Filed 01/06/11 Page 2 of 10 PageID: 2
Case 3:11-cv-00090-AET-LHG Document 1 Filed 01/06/11 Page 3 of 10 PageID: 3
Case 3:11-cv-00090-AET-LHG Document 1 Filed 01/06/11 Page 4 of 10 PageID: 4
Case 3:11-cv-00090-AET-LHG Document 1 Filed 01/06/11 Page 5 of 10 PageID: 5
Case 3:11-cv-00090-AET-LHG Document 1 Filed 01/06/11 Page 6 of 10 PageID: 6
Case 3:11-cv-00090-AET-LHG Document 1 Filed 01/06/11 Page 7 of 10 PageID: 7
Case 3:11-cv-00090-AET-LHG Document 1 Filed 01/06/11 Page 8 of 10 PageID: 8
Case 3:11-cv-00090-AET-LHG Document 1 Filed 01/06/11 Page 9 of 10 PageID: 9
Case 3:11-cv-00090-AET-LHG Document 1 Filed 01/06/11 Page 10 of 10 PageID: 10
EXHIBIT
      23.2




Consent
      of Registered Independent Public Accounting Firm




We
      consent to the incorporation by reference in the Registration Statement (Form
      S-8 No. 333-124594) of our report dated March 5, 2004, with respect to the
      2003
      financial statements of Patient Safety Technologies, Inc. formerly Franklin
      Capital Corporation included in this Annual Report (10-K) for the year ended
      December 31, 2005.





/s/
      ERNST
& YOUNG LLP




New
      York,
      New York


May
      31,
      2007
Case 2:11-cr-00075-DMC Document 15 Filed 08/15/11 Page 1 of 2 PageID: 38
Case 2:11-cr-00075-DMC Document 15 Filed 08/15/11 Page 2 of 2 PageID: 39
WARNING: THE EDGAR SYSTEM ENCOUNTERED ERROR(S) WHILE PROCESSING THIS SCHEDULE.

<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
The schedule contains summary financial information extracted from the
registrant's consolidated financial statements for the year ended November 30,
1995 and is qualified in it's entirety by reference to such financial
statements.
</LEGEND>
<MULTIPLIER> 1000
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          NOV-30-1995
<PERIOD-END>                               NOV-30-1995
<CASH>                                              61
<SECURITIES>                                         0
<RECEIVABLES>                                    26142
<ALLOWANCES>                                    (2147)
<INVENTORY>                                      15276
<CURRENT-ASSETS>                                 40677
<PP&E>                                          173065
<DEPRECIATION>                                 (90700)
<TOTAL-ASSETS>                                  146243
<CURRENT-LIABILITIES>                            37647
<BONDS>                                          18275
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            59
<OTHER-SE>                                       90262
<TOTAL-LIABILITY-AND-EQUITY>                    146243
<SALES>                                         137236
<TOTAL-REVENUES>                                137236
<CGS>                                           129253
<TOTAL-COSTS>                                   129253
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                   330
<INTEREST-EXPENSE>                                 633
<INCOME-PRETAX>                                    705
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                705
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                       705
<EPS-PRIMARY>                                      .12
<EPS-DILUTED>                                     
        

</TABLE>
ImmuCell Corporation

EXHIBIT 32

CERTIFICATION PURSUANT TO SECTION 1350, AS ADOPTED PURSUANT TO SECTION

906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report on Form 10-K of ImmuCell Corporation (the Company) for the period ended December 31, 2010, as filed with the Securities and Exchange Commission on the
date hereof (the Report), I, Michael F. Brigham, President, Chief Executive Officer and Treasurer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934;
and

(2) the information contained in the Report fairly presents, in all material respects, the financial condition, results
of operations and cash flows of the Company.

This certification is provided pursuant to 18 U.S.C. Section 1350 and
Item 601(b)(32) of Regulation S-K (Item 601(b)(32)) promulgated under the Securities Act of 1933, as amended (the Securities Act), and the Securities Exchange Act of 1934, as amended (the Exchange Act). In accordance with clause (ii) of
Item 601(b)(32), this certification (A) shall not be deemed filed for the purposes of Section 18 of the Exchange Act, or otherwise subject to the liability of that section, and (B) shall not be deemed to be
incorporated by reference into any filing under the Securities Act or the Exchange Act, except to the extent that the Company specifically incorporates it by reference.



|                                                
|------------------------------------------------
|/s/ Michael F. Brigham                          
|Michael F. Brigham                              
|President, Chief Executive Officer and Treasurer
|March 28, 2011                                  

A signed original of this written
statement required by Section 906 has been provided to ImmuCell Corporation and will be retained by ImmuCell Corporation and furnished to the Securities and Exchange Commission or its staff upon request.
##### 



Exhibit 31.1
 Certification of Chief Executive Officer
of Periodic Report Pursuant to Rule 13a-14(a)
  1.
    
    I have reviewed this Quarterly Report on Form 10-Q for the fiscal quarter ended May 31, 2007
of Kayne Anderson Energy Development Company;2.
    
    Based on my knowledge, this report does not contain any untrue statement of a material fact
or omit to state a material fact necessary to make the statements made, in light of the
circumstances under which such statements were made, not misleading with respect to the period
covered by this report;3.
    
    Based on my knowledge, the financial statements, and other financial information included in
this report, fairly present in all material respects the financial condition, results of
operations and cash flows of the registrant as of, and for, the periods presented in this
report;4.
    
    The registrants other certifying officer(s) and I are responsible for establishing and
maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and
15d-15(e)) for the registrant and have:
 a.
    
    Designed such disclosure controls and procedures, or caused such disclosure controls and
procedures to be designed under our supervision, to ensure that material information
relating to the registrant, including its consolidated subsidiaries, is made known to us by
others within those entities, particularly during the period in which this report is being
prepared;b.
    
    Evaluated the effectiveness of the registrants disclosure controls and procedures and
presented in this report our conclusions about the effectiveness of the disclosure controls
and procedures, as of the end of the period covered by this report based on such evaluation;
andc.
    
    Disclosed in this report any change in the registrants internal control over financial
reporting that occurred during the registrants most recent fiscal quarter (the registrants
fourth fiscal quarter in the case of an annual report) that has materially affected, or is
reasonably likely to materially affect, the registrants internal control over financial
reporting; and
 5.
    
    The registrants other certifying officer(s) and I have disclosed, based on our most recent
evaluation of internal control over financial reporting, to the registrants auditors and the
audit committee of the registrants board of directors (or persons performing the equivalent
functions):
 a.
    
    All significant deficiencies and material weaknesses in the design or operation of
internal control over financial reporting which are reasonably likely to adversely affect
the registrants ability to record, process, summarize and report financial information; andb.
    
    Any fraud, whether or not material, that involves management or other employees who have
a significant role in the registrants internal control over financial reporting.
  /s/ Kevin S. McCarthyKevin S. McCarthyChief Executive Officer(Principal Executive Officer)
 30
```

[Congressional Bills 116th Congress]
[From the U.S. Government Publishing Office]
[H. Res. 95 Introduced in House (IH)]

<DOC>

116th CONGRESS
  1st Session
H. RES. 95

  Expressing support for designation of February 4, 2019, as National 
                         Cancer Prevention Day.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                            February 4, 2019

   Mrs. Dingell (for herself and Mr. Upton) submitted the following 
 resolution; which was referred to the Committee on Energy and Commerce

_______________________________________________________________________

                               RESOLUTION

 
  Expressing support for designation of February 4, 2019, as National 
                         Cancer Prevention Day.

Whereas National Cancer Prevention Day is a day to remind us that when looking 
        at cancer we need to look at prevention and reducing risks for human 
        health and the environment;
Whereas when we work to prevent cancer risks, it impacts human health, the 
        environment, and the economy;
Whereas cancer is one of the leading causes of death around the world and has 
        touched the lives of nearly everyone, either directly or indirectly;
Whereas cancer is the cause of nearly 1 out of every 4 deaths in the United 
        States;
Whereas in 2019, there will be an estimated 1,762,450 new cancer cases diagnosed 
        and 606,880 cancer deaths in the United States;
Whereas cancer is the second most common cause of death among children ages 1 to 
        14 years in the United States after accidents, and in 2019 an estimated 
        11,060 children in this age group will be diagnosed with cancer and 
        1,190 will die from it; and
Whereas February 4, 2019, would be an appropriate date to designate as Cancer 
        Prevention Day: Now, therefore, be it
    Resolved, That the House of Representatives--
            (1) supports the designation of National Cancer Prevention 
        Day;
            (2) recognizes all efforts to raise the awareness for the 
        reduction of cancer risks; and
            (3) recognizes the devastating effect cancer has on 
        families and wishes to expand knowledge, encourage early 
        detection, and work with friends in the medical and scientific 
        fields to put an end to this deadly disease.
                                 <all>
```
COURT OF APPEALS FOR THE

FIRST DISTRICT OF TEXAS AT HOUSTON

ORDER

Appellate case name: Brandy Silman v. U.S. Bank, N.A.

Appellate case number: 01-15-00364-CV

Trial court case number: 29,587

Trial court: 335th District Court of Bastrop County

On March 24, 2015, appellant, Brandy Silman, proceeding pro se, filed an 

affidavit of indigence in the trial court with her notice of appeal in the above-referenced 

trial court proceeding. See TEX. R. APP. P. 20.1(a)(2). On April 13, 2015, the court 

reporter filed an information statement that there was no reporter’s record taken.1 On 

April 22, 2015, the clerk’s record was filed, including the appellant’s affidavit of 

indigence, but there was no indication whether there was a contest to the affidavit filed.

On June 26, 2015, the Clerk of this Court requested an indigent clerk’s record be 

filed by the trial clerk. See TEX. R. APP. P. at 20.1(c)(1), (d)(1), (e)(1). On July 2, 2015, 

the trial clerk filed a cover letter, dated June 29, 2015, in this Court stating that no contest 

to the affidavit of indigence was timely filed in the trial court. See id. at 20.1(e)(1).

Accordingly, the allegations in the affidavit of indigence are deemed true, and 

appellant is entitled to proceed without advance payment of appellate costs. See TEX. R.

APP. P. at 20.1(f). The Clerk of this Court is ORDERED to deem the appellant indigent 

and to order that she is allowed to proceed on appeal without advance payment of costs

for purposes of the appellate filing fee and the clerk’s record fees.

It is so ORDERED.

Judge’s signature: /s/ Evelyn V. Keyes

 Acting individually 

Date: July 28, 2015

 

1

Pursuant to the Texas Supreme Court’s docket equalization powers, this appeal was 

transferred from the Third Court of Appeals to this Court on April 21, 2015. See TEX.

GOV’T CODE ANN. § 73.001 (West Supp. 2014); Order Regarding Transfer of Cases 

From Courts of Appeals, Misc. Docket No. 15-9054, ¶ II (Tex. Mar. 24, 2015).
**CERTIFICATION OF					CHIEF EXECUTIVE OFFICER					AND					CHIEF FINANCIAL OFFICER PURSUANT TO					18 U.S.C. SECTION 1350,					AS ADOPTED PURSUANT TO					SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

I, Ken MacAlpine, Chief Executive Officer and Chief Financial Officer of NABO Inc. (the “Company”), hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

> 
(i)     

the Quarterly Report on Form 10-QSB of the Company for the fiscal quarter ended September 30, 2006 (the “Quarterly Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

   

 

(ii)

the information contained in the Quarterly Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

|   | By:                | */s/ Ken MacAlpine                              * |
|--------|--------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|   |          |                                                                                                                                                                                                    |
|   | Name:              | Ken MacAlpine                                                                                                                                                                                           |
|   |     |                                                                                                                                                                                                    |
|   | Title:             | Chief Executive Officer and                                                                                                                                                                             |
|   |               | Chief Financial Officer                                                                                                                                                                                 |
|   |     |                                                                                                                                                                                                    |
|   | Date:              | November 9, 2006                                                                                                                                                                                        |

----
EXHIBIT 32.1

                    CERTIFICATION OF CHIEF EXECUTIVE OFFICER
                       PURSUANT TO 18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Maple Mountain Explorations Inc. (the
"Company") on Form 10-QSB for the period ending July 31, 2007 as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), I, Marvin
Wosk, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C.
ss.1350, as adopted pursuant to ss.906 of the Sarbanes-Oxley Act of 2002, that:

     (1)  The Report fully  complies with the  requirements  of section 13(a) or
          15(d) of the Securities Exchange Act of 1934; and

     (2)  The  information  contained  in the  Report  fairly  presents,  in all
          material respects, the financial condition and result of operations of
          the Company.

IN WITNESS WHEREOF, the undersigned has executed this certification as of the
13th day of September, 2007.


/s/ Marvin Wosk
---------------------------
Chief Executive Officer
#### The People of the State of New York, Respondent, v Mei Ying Wang, Appellant.

[826 NYS2d 285]

*821Appeal by the defendant from a judgment of the County Court, Suffolk County (Corso, J.), rendered December 13, 2002, convicting him of murder in the second degree, after a nonjury trial, and imposing sentence.

Ordered that the judgment is affirmed.

Contrary to the defendant’s contention, he was not denied the effective assistance of counsel. Viewing the record as a whole, we conclude that the defendant received meaningful representation *(see People v Benevento,*91 NY2d 708, 712 [1998]; *People v Baldi,*54 NY2d 137 [1981]).

Under CPL 250.10 (2), psychiatric evidence is not admissible by the defense at trial “unless the defendant serves upon the people and files with the court a written notice of his intention to present psychiatric evidence . . . before trial and not more than thirty days after entry of the plea of not guilty to the indictment.” The decision whether to allow a defendant, in the “interest of justice and for good cause shown,” to serve and file a late notice of intent to introduce psychiatric evidence is a discretionary determination to be made by the trial court *(People v Berk,*88 NY2d 257, 265-266 [1996], *cert denied*519 US 859 [1996]; *People v Conley,*11 AD3d 706, 707 [2004]). However, it is undisputed that the defense counsel never served any written CPL 250.10 notice. The only pretrial notice established by the record was an oral notice provided immediately before trial.

The court did not improvidently exercise its discretion in denying the defendant’s request for an adjournment to allow him to serve and file a late notice *(see People v Rivers,*281 AD2d 348, 349 [2001]). The defendant did not demonstrate good cause for his failure to serve and file a notice. The record reflects that the defendant had ample time to serve and file a notice of his intention to present psychiatric evidence, and did not present any reason for his failure to do so *(see People v Brown,*4 AD3d 886, 887 [2004], quoting *People v Rizzo,*267 AD2d 1041, 1042 [1999]).

The defendant’s contention that the People failed to prove by legally sufficient evidence that he intended to cause the victim’s death is without merit. Viewing the evidence in the light most favorable to the prosecution *(see People v Contes,*60 NY2d 620 [1983]), we find that it was legally sufficient to establish the defendant’s guilt of murder in the second degree beyond a reasonable doubt *(see*Penal Law § 125.25 [1]; *People v Jones,*309 AD2d 819, 820 [2003]). The defendant’s intent may be inferred from his conduct and the surrounding circumstances *(see People v Bracey,*41 NY2d 296, 303 [1977]; *People v Hernandez,*257 AD2d 664, 665 [1999]). Moreover, upon the exercise of our *822factual review power, we find that the verdict of guilt was not against the weight of the evidence *(see*CPL 470.15 [5]).

The sentence imposed was not excessive *(see People v Suitte,*90 AD2d 80 [1982]). Adams, J.R, Goldstein, Mastro and Lifson, JJ., concur.
UNPUBLISHED UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT No. 99-7257

UNITED STATES OF AMERICA, Plaintiff - Appellee, versus BONITA R. DEMBY, Defendant - Appellant.Appeal from the United States District Court for the Eastern District of Virginia, at Alexandria. Claude M. Hilton, Chief District Judge. (CR-96-440, CA-99-314-AM) Submitted: December 16, 1999 Decided: January 10, 2000Before MURNAGHAN and MOTZ, Circuit Judges, and BUTZNER, Senior Circuit Judge. Dismissed by unpublished per curiam opinion. Bonita R. Demby, Appellant Pro Se. Randy I. Bellows, OFFICE OF THE UNITED STATES ATTORNEY, Alexandria, Virginia, for Appellee. Unpublished opinions are not binding precedent in this circuit. See Local Rule 36(c).* Although the district court’s order is marked as “filed” on August 12, 1999, the district court’s records show that it was entered on the docket sheet on August 16, 1999. Pursuant to Rules 58 and 79(a) of the Federal Rules of Civil Procedure, it is the date that the order was entered on the docket sheet that we take as the effective date of the district court’s decision. See Wilson v. Murray , 806 F.2d 1232, 1234-35 (4th Cir. 1986). 2 PER CURIAM:Bonita R. Demby seeks to appeal the district court’s order denying her motion filed under 28 U.S.C.A. § 2255 (West Supp. 1999). We have reviewed the record and the district court’s opinion and find no reversible error. Accordingly, we deny a certificate ofappealability and dismiss the appeal on the reasoning of the district court. See United States v. Demby, Nos. CR-96-440; CA-99- 314-AM (E.D. Va. Aug. 16, 1999). * We dispense with oral argument because the facts and legal contentions are adequately presented in the materials before the court and argument would not aid the decisional process.

DISMISSED